Eri Kato

45 papers · 7.2k indexed citations

Standout Papers

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus (2019)
Thomas A. Zelniker, Stephen D. Wiviott et al. Circulation
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes (2018)
Stephen D. Wiviott, Itamar Raz et al. New England Journal of Medicine
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials (2018)
Thomas A. Zelniker, Stephen D. Wiviott et al. The Lancet

Immediate Impact

2 from Science/Nature 88 standout

Sub-graph 1 of 16

Citing Papers

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

2024 Standout

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

2024 Standout

Works of Eri Kato being referenced

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

2019 Standout

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

2018 Standout

Author Peers

Author						Papers	Cites
Eri Kato	5783	180	1916	2397	2396	45	7.2k
Ingrid Gause‐Nilsson	5914	20	1585	2606	2401	68	7.3k
Wayne Shaw	6814	17	1820	2670	2919	36	8.1k
Thomas A. Zelniker	6545	57	2385	2744	2725	67	8.4k
Michael G. Silverman	4282	65	1924	1826	2556	42	6.5k
Julia Kuder	4736	61	3030	1865	3409	59	8.4k
Greg Fulcher	7548	40	1783	2847	3312	62	9.2k
Mehul Desai	7621	38	1903	3202	3333	49	9.2k
Avivit Cahn	7371	33	1944	3007	2872	111	8.8k
Hans J. Woerle	8196	32	2316	3407	3447	24	9.7k
Gordon Law	5004	12	1199	2081	2058	12	6.1k

All Works

Loading papers...